Janet H Van Cleave
MBA PhD
Assistant Professor
janet.vancleave@nyu.edu
1 212 992 7340
Janet H Van Cleave's additional information
-
-
Janet Helen Van Cleave, PhD, is an assistant professor at NYU Rory Meyers College of Nursing. Her program of research is focused on symptom science and mHealth technology use in cancer. She is an oncology nurse and nurse scientist whose career goal is to improve the quality of care for patients with cancer.
Van Cleave developed the Electronic Patient Visit Assessment (ePVA)© for head and neck cancer for early detection and intervention for debilitating symptoms. Her program of research has received both federal and foundation funding. She has published in high-impact scientific journals and online magazines like WIRED.
Among her many awards, she received the Poster of Distinction by the International Federation of Head and Neck Oncologic Societies and the 2014 CANCER NURSING Research Award. She was a fellow of the American Psychosocial Oncology Society Conference in New Orleans, LA.
Van Cleave received her PhD from Yale University and completed post-doctoral training at the NewCourtland Center for Transitions and Health at the University of Pennsylvania School of Nursing. She earned her MS and BS in nursing from the University of Pennsylvania.
-
-
Post-Doctoral Research Fellow - University of Pennsylvania (2010)PhD - Yale University (2008)MSN - University of Pennsylvania (1995)BSN - University of Pennsylvania (Summa Cum Laude, 1994)Diploma of Nursing - St. Luke’s Hospital School of Nursing (1983)MBA - University of Kansas (1978)BA - Kansas State University (1976)
-
-
Gerontology
-
-
Academy HealthAmerican Psychosocial Oncology SocietyGerontological Society of AmericaInternational Association for the Study of PainOncology Nursing Society
-
-
Faculty Honors Awards
Mayday Pain & Society Fellowship, The Mayday Fund (2019)ENRS/Nursing Research Authorship Award, Eastern Nursing Research Society (2017)Poster of Distinction, International Federation of Head and Neck Oncologic Societies (2014)Fellowship, American Psychosocial Oncology Society Conference, New Orleans, LA (2010)Scholarship, 8th National Conference on Cancer Nursing Research, John A. Harford Foundation Policy Leadership Institute Oncology Nursing Society/American Cancer Society (2009)Outstanding Colleague, Mount Sinai Medical Center (2004)Best Article, Oncology Nursing Society Special Interest Group Newsletter Editor (2004)Nominee, Clinical Excellence Award, Mount Sinai Medical Center (2002)Unit Recognition Award for Special Clinics, Philadelphia Veterans Affairs Medical Center (2000)Health Professional Scholarship, Department of Veterans Affairs (1994)Sigma Theta Tau, University of Pennsylvania School of Nursing (1994)Joan Ethel Huebner Award for High GPA, University of Pennsylvania School of Nursing (1994) -
-
Publications
A Scoping Review of Nursing's Contribution to the Management of Patients with Pain and Opioid Misuse
Failed retrieving data.Multidimensional Pain Assessment Tools for Ambulatory and Inpatient Nursing Practice
Failed retrieving data.The development, usability, and reliability of the Electronic Patient Visit Assessment (ePVA) for head and neck cancer
Failed retrieving data.The Effect of Glucose Levels Prior to Hematopoietic Cell Transplantation on Post-Transplant Complications and Health Resource Utilization
Failed retrieving data.The Experience of Being Aware of Disease Status in Women with Recurrent Ovarian Cancer: A Phenomenological Study
Failed retrieving data.Mental health and substance use disorders in patients diagnosed with cancer: An integrative review of healthcare utilization
AbstractWoersching, J., Van Cleave, J. H., Haber, J., & Chyun, D. (2019). Oncology Nursing Forum, 46(3), 365-383. 10.1188/19.ONF.365-383AbstractPROBLEM IDENTIFICATION: The impact of mental health disorders (MHDs) and substance use disorders (SUDs) on healthcare utilization (HCU) in patients with cancer is an understudied phenomenon. LITERATURE SEARCH: A literature search of studies published prior to January 2018 that examined HCU in patients with preexisting MHDs or SUDs diagnosed with cancer was conducted. DATA EVALUATION: The research team evaluated 22 studies for scientific rigor and examined significant trends in HCU, as well as types of the MHD, SUD, and cancer studied. SYNTHESIS: The heterogeneity of HCU outcome measures, MHD, SUD, sample sizes, and study settings contributed to inconsistent study findings. However, study trends indicated higher rates of HCU by patients with depression and lower rates of HCU by patients with schizophrenia. In addition, the concept of HCU measures is evolving, addressing not only volume of health services, but also quality and efficacy. IMPLICATIONS FOR RESEARCH: Oncology nurses are essential to improving HCU in patients with MHDs and SUDs because of their close connections with patients throughout the stages of cancer care. Additional prospective studies are needed to examine specific MHDs and different types of SUDs beyond alcohol use, improving cancer care and the effectiveness of HCU in this vulnerable population.Can Multidimensional Pain Assessment Tools Help Improve Pain Outcomes in the Perianesthesia Setting?
Failed retrieving data.Frailty in Older Adults: Assessment, Support, and Treatment Implications in Patients With Cancer
Failed retrieving data.Moving Beyond Pain as the Fifth Vital Sign and Patient Satisfaction Scores to Improve Pain Care in the 21st Century
Failed retrieving data.Identifying distinct risk profiles to predict adverse events among community-dwelling older adults
Failed retrieving data. -
-
Media
-